Ten-year-old Emma didn’t ask for toys. She didn’t ask for a trip. She asked for... a wedding. Emma Brooks Edwards was 10 years old, living in North Carolina and battling acute lymphoblastic leukemia, ...

Chief Executive Officer Christian Itin told conference attendees the company is entering its second year as a commercial-stage business following the launch of its first product, obe-cel, a CD19 CAR-T ...

Researchers at the Sanford Stem Cell Institute have taken the fight against rare diseases to the lab, to patients’ bedsides ...

Lacey High School senior Alex Pastore had a cough he just couldn't shake. It turned out to be T-cell acute lymphoblastic ...

Acute Lymphocytic Leukemia (ALL) is a serious type of cancer that affects the blood and bone marrow. It moves very quickly, meaning it needs fast and strong treatment. In ALL, the body starts making ...

As a 12-year-old boy, an athlete and a twin brother, competitiveness was just second nature to Long Island native, Charlie ...

According to MarketsandMarkets™, the CAR T-Cell Therapy Market is estimated to reach USD 13.78 billion by 2031 from USD 7.24 ...

Several potentially practice-changing phase 3 trials alongside promising results in emerging strategies in chronic lymphocytic leukemia (CLL) presented at the 2025 American Society of Hematology ...

This is read by an automated voice. Please report any issues or inconsistencies here. Amgen, a Thousand Oaks-based biotechnology giant, has acquired Dark Blue Therapeutics Ltd., a privately held ...

The 6-year-old Secane girl fighting her second round with leukemia is now collecting Band-Aids for the nurses at Children’s Hospital of Philadelphia in a campaign called Love That Sticks. Ella Blohm ...

PREPARE-ALL was developed using data from the ICiCLe ALL-14 pretrial cohort across five centers, incorporating 33 clinical and laboratory features. Among 2,252 patients enrolled in the study, 565 ...